Toronto Dominion Bank
ARLZ

Toronto Dominion Bank’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Toronto Dominion Bank’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-618
Closed – – 1697
2018
Q2 		$0 Buy
618
+609
+6,767% +$500 ﹤0.01% 1657
2018
Q1 		$0 Sell
9
-126
-93% -$220 ﹤0.01% 1513
2017
Q4 		$0 Sell
135
-137
-50% -$225 ﹤0.01% 1373
2017
Q3 		$1K Sell
272
-9
-3% -$12 ﹤0.01% 1147
2017
Q2 		$0 Sell
281
-35
-11% -$51 ﹤0.01% 1359
2017
Q1 		$1K Buy
316
+44
+16% +$165 ﹤0.01% 1186
2016
Q4 		$1K Hold
272
– – ﹤0.01% 1220
2016
Q3 		$1K Sell
272
-85
-24% -$388 ﹤0.01% 1188
2016
Q2 		$1K Buy
357
+327
+1,090% +$1.23K ﹤0.01% 1179
2016
Q1 		$0 Buy
+30
New +$155 ﹤0.01% 1367

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Toronto Dominion Bank's ARLZ Position: Q3 2018 in Review

Toronto Dominion Bank sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 618 shares.

Toronto Dominion Bank first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $1K in Q3 2017. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Toronto Dominion Bank reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Toronto Dominion Bank sold 618 Aralez Pharmaceuticals Inc. shares in Q3 2018.
  • Toronto Dominion Bank first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
  • Toronto Dominion Bank's Aralez Pharmaceuticals Inc. position peaked at $1K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Toronto Dominion Bank's 13F filing for Q3 2018, filed 7 Nov 2018.